Skeletal consequences of discontinuation of growth hormone at final height

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue SUPPL. 5, 2002, Pages 1351-1354

  Drake, William M ^a   Carroll, Paul V ^a   Savage, Martin O ^a   Monson, John P ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Bone mass; Final height; Growth hormone; Growth hormone deficiency; Skeletal consequences

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE DENSITY; BONE GROWTH; BONE MASS; BONE MINERALIZATION; CLINICAL PRACTICE; CLINICAL TRIAL; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HORMONE ACTION; HUMAN; OSTEOPOROSIS; PATHOLOGIC FRACTURE; RISK ASSESSMENT; TREATMENT WITHDRAWAL;

BODY HEIGHT; BONE AND BONES; BONE DENSITY; HUMAN GROWTH HORMONE; HUMANS;

EID: 0036914216     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jorgensen JO, Pedersen S, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebæk N, Christiansen J. Beneficial effects of growth hormone treatment in GH deficient adults. Lancet 1989; i: 1221-1225.
2. Salomon F, Cuneo RC, Hesp R, Sönksen P. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321: 1797-1803.
3. Carroll PV, Christ ER, Bengtsson BÅ, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sönksen PH, Tanaka T, Thorne M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998; 83: 382-395.
4. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BÅ. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 1997; 137: 240-245.
5. Matkovic V, Jelic T, Wardlaw G, Ilich J, Goel P, Wright J, Andon M, Smith K, Heaney R. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis: inference from a cross-sectional model. J Clin Invest 1994; 93: 799-808.
6. Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991; 73: 555-563.
7. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, Bonjour JP. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75: 1060-1065.
8. Rizzoli R, Bonjour JP. Determinants of peak bone mass and mechanisms of bone loss. Osteoporosis Int 1999; 9 (Suppl 2): S17-S23.
9. Ernst M, Froesch ER. Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochem Biophys Res Commun 1988; 151: 142-147.
10. Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MP, van der Meer JM, Duursma SA. Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells. J Endocrinol 1988; 116: R11-13.
11. Slootweg MC, Buul-Offers SC, Herrmann-Erlee MP, Duursma SA. Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture. Acta Endocrinol 1988; 118: 294-300.
12. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994; 78: 669-674.
13. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992; 74: 118-123.
14. Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999; 84: 1919-1924.
15. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. Bone mineral status in growth hormone deficiency. J Pediatr 1980; 96: 393-396.
16. Zamboni G, Antoniazzi F, Radetti G, Musumeci C, Tató L. Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J Pediatr 1991; 119: 483-485.
17. Saggese G, Baroncelli GI, Bertelloni S, Cinqunata L, Di Nero G. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 1993; 122: 37-45.
18. Compston JE, Evans WD, Crawley EO, Evans C. Bone mineral content in normal UK subjects. Br J Radiol 1988; 61: 631-636.
19. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996; 81: 3077-3083.
20. Boot AM, Engels MA, Boerma GJ, Krenning EP, de Muinck Keizer-Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 1997; 82: 2423-2428.
21. Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G. Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency. J Clin Endocrinol Metab 1998; 83: 3150-3154.
22. de Boer H, Blok GJ, van Lingen A, Teule GJ, Lips P, van der Veen EA. Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 1994; 9: 1319-1326.
23. Ogle GD, Moore B, Lu PW, Craighead A, Briody JN, Cowell CT. Changes in body composition and bone density after discontinuation of growth hormone therapy in adolescence: an interim report. Acta Paediatr 1994; Suppl 399: 3-7; discussion 8.
24. Brennan BM, Rahim A, Adams JA, Eden OB, Shalet SM. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood, Br J Cancer 1999; 79: 1859-1863.
25. Drake WM, Carroll PV, Maher KT, Metcalfe KA, Shaw NJ, Dunger DB, Cheetham TD, Camacho-Hubner C, Savage MO, Monson JP. Discontinuation of growth hormone (GH) at final height in GDH adolescents results in arrested bone mineralisation and reduced bone remodelling. Annual Meeting of the Endocrine Society, San Francisco, 2002; Abstract OR 50-6.
26. Johannsson G, Albertsson-Wikland K, Bengtsson BÅ. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. J Clin Endocrinol Metab 1999; 84: 4516-4524.